Can antimicrobial susceptibility testing results for ciprofloxacin or levofloxacin predict susceptibility to a newer fluoroquinolone, gatifloxacin?: Report from The SENTRY Antimicrobial Surveillance Program (1997-99)

Diagnostic Microbiology and Infectious Disease

Volumn 39, Issue 4, 2001, Pages 237-243

  Jones, Ronald N ^a,b   Pfaller, Michael A ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b JMI LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 METHOXYFLUOROQUINOLONE; CIPROFLOXACIN; GATIFLOXACIN; LEVOFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; UNCLASSIFIED DRUG;

ANTIBIOTIC SENSITIVITY; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ERROR; DIAGNOSTIC VALUE; DISEASE MARKER; DRUG POTENCY; DRUG SURVEILLANCE PROGRAM; ENTEROBACTERIACEAE; ENTEROCOCCUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SPECIES DIFFERENCE; STAPHYLOCOCCUS; STREPTOCOCCUS PNEUMONIAE;

ANTI-INFECTIVE AGENTS; CIPROFLOXACIN; DATABASES, FACTUAL; ENTEROBACTERIACEAE; FLUOROQUINOLONES; GRAM-POSITIVE COCCI; HUMANS; MICROBIAL SENSITIVITY TESTS; OFLOXACIN; PREDICTIVE VALUE OF TESTS; PSEUDOMONAS AERUGINOSA;

EID: 0034988038     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(01)00229-2     Document Type: Article

References (18)

1. Cross susceptibility and absence of cross resistance to cefotetan and cefoxitin
2. Comparison of the antibacterial activities of the quinolones BAY 12-8039, gatifloxacin (AM-1155), trovafloxacin, clinafloxacin, levofloxacin, and ciprofloxacin
3. Levofloxacin: A review of its antibacterial activity, pharmacokinetics and therapeutic efficacy
4. Instrument-based antibacterial susceptibility testing
5. Antibacterial properties of AM-1155, a new 8-methoxy quinolone
6. In vitro and in vivo antibacterial activities of AM-1155, a new 6-fluoro-methoxy quinolone
7. Activity of gatifloxacin against Haemophilus influenzae and Moraxella catarrhalis, including susceptibility test development, Etest comparisons, and quality control guidelines for H. influenzae
8. Antimicrobial activity evaluations of gatifloxacin, a new fluoroquinolone: Contemporary pathogen results from a global antimicrobial resistance surveillance program (SENTRY, 1997)
9. Comparative antimicrobial activity of gatifloxacin tested against Streptococcus spp. including quality control guidelines and Etest method validation
10. Gatifloxacin (AM-1155, CG 5501) susceptibility testing interpretive criteria and quality control guidelines for dilution and disk (5-μg) diffusion methods
11. Prediction of bacterial susceptibility to cefpodoxime by using the ceftriaxone MIC result
12. Selection criteria for an antimicrobial susceptibility testing system
13. Bacterial pathogens isolated from patients with blood stream infection: Frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997)
14. In vitro antibacterial activity of AM-1155, a novel 6-fluoro-8-methoxy quinolone